We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Date
Sponsor content
1144 result(s) found, displaying 611 to 620
-
Prescription medicine registrationActive ingredients: Rosuvastatin calcium, Ezetimibe.
-
Prescription medicine registrationActive ingredients: fenofibrate.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BUPRENORPHINE SANDOZ buprenorphine 20 micrograms/hour transdermal drug delivery system sachet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BUPRENORPHINE SANDOZ buprenorphine 15 micrograms/hour transdermal drug delivery system sachet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BUPRENORPHINE SANDOZ buprenorphine 5 micrograms/hour transdermal drug delivery system sachet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BUPRENORPHINE SANDOZ buprenorphine 10 micrograms/hour transdermal drug delivery system sachet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FINGOLIMOD SANDOZ fingolimod (as hydrochloride) 0.5 mg capsule blister pack.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 16/12/2019